Butterfly Network Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Butterfly Network Inc in the second quarter 2026?
Butterfly Network Inc recorded a cumulative net loss of $-75 million during 12 months ending in the second quarter 2026, resulting in a negative return on equity (ROE) of -38.36%.

Within the Medical Laboratories industry 23 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2026 from 3035 to 3104.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Equity Change	-18.64 %	-20.22 %	16.08 %	12.1 %	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in Millions	-75	-76	-77	-80	-63
Return On Equity (TTM)	-38.36 %	-36.79 %	-35.34 %	-37.8 %	-30.53 %
BFLY's Total Ranking	# 3104	# 3035	# 2379	# 2778	# 2380
Equity (TTM) in Millions	189	191	196	204	233
Seq. Equity Change	-0.95 %	-2.43 %	-3.85 %	-12.45 %	-2.87 %
Seq. Net Income Change	-	-	-	-	-

Back to BFLY Management Effectiveness >> BFLY's 5 Years Annual ROE >> Compare BFLY ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 24
Sector	# 358
Overall	# 3104

Return On Equity Statistics
High	Average	Low
-7.28 %	-53.31 %	-276.62 %
		(Mar 31 2013)

News about Butterfly Network Inc Return on Equity ROE

Butterfly Network Soars Innovating Healthcare at Every Turn

In the rapidly evolving landscape of digital health technology, Butterfly Network, Inc. (NYSE: BFLY) is making significant strides that position the company as a key player in the industry. Their commitment to transforming care through portable, high-quality ultrasound technology is underscored by a series of recent announcements that highlight both their innovations and strategic engagements aimed at expanding their market presence. Participation in Key Industry Forum On November 21, 2024, Butterfly Network will participate in the prestigious Canaccord Genuity MedTech, Diagnostics and Digital Health and Services Forum in New York City. This forum is a vital opportunity for Butterfly Network s President, Chief Executive Officer, and Chairman, Joseph DeVivo, and Executive Vice President and Chief Financial Officer, Heather Getz, to engage with investors, industry leaders, and stakeholders. Their participation suggests a robust visibility strategy aimed at enhancing investor confidence and showcasing advancements in their technology. The forum also reflects a broader trend where companies in the medtech space are increasingly aligning with financial markets to facilitate growth and investment opportunities.

BFLY Annual Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Equity in Millions	196	169	220	325	448
Y / Y Equity Change	16.08 %	-23.28 %	-32.37 %	-27.32 %	-
Net Income in Millions	-77	-72	-134	-169	-32
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	-39.32 %	-42.94 %	-60.76 %	-51.86 %	-7.24 %

Back to BFLY Management Effectiveness >> BFLY's 5 Years Annual ROE >> Compare BFLY ROE to its Competitors

More Return On Equity Ratios
Medical Laboratories Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
BFLY's' Return on Equity at Yahoo Finance
BFLY's Roe Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for BFLY's Competitors
Subscribers only: Roe for Butterfly Network Inc 's Suppliers
Subscribers only: Return On Equity for BFLY's Customers

Companies with similar Return On Equity at Jun 30 2026, within Healthcare Sector

ROE

Date modified: 2026-09-12T18:15:39+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.